Similar Articles

NLRP3 Inflammasome: A New Target in Psychiatric Disorders

Sevda Çelik, Aylin Kayaaltı, Oytun Erbaş

DOI: 10.5606/jebms.2021.75681

Issue: 2021, Volume 2 - Issue 3
3781 1643

Glutamate Receptor Activity in Neuropsychiatric Disorders

Damla Koyun, Merve Nur Sevinç, İlknur Altuntaş, Oytun Erbaş

DOI: 10.5606/jebms.2022.1009

Issue: 2022, Volume 3 - Issue 1
2308 1204

Understanding the Role of DISC1 in Psychiatric Disorders

Şeyda Yazıcı, Hadi Sasani, Oytun Erbaş

DOI: 10.5606/jebms.2022.1011

Issue: 2022, Volume 3 - Issue 1
5189 1652

Human Prefrontal Cortex: Regions and Functions

Ece Sarı, Oytun Erbaş

DOI: 10.5606/jebms.2022.1020

Issue: 2022, Volume 3 - Issue 2
11815 3096

Evidence for Genetic Relationships in Attention-Deficit Hyperactivity Disorder

Büşra Candan Balkan, Kerem Can Tunç, Oytun Erbaş

DOI: 10.5606/jebms.2022.1036

Issue: 2022, Volume 3 - Issue
3208 1230

Non-Coding RNAs in Brain Function and Disorders

Buse Kaptan, Mai Abusalim, Oytun Erbaş

DOI: 10.5606/jebms.2023.1042

Issue: 2023, Volume 4 - Issue 1
1811 1195

Endoplasmic Reticulum Stress: Implications for Psychiatric Disorders

Ecren Büyükada, Ejder Saylav Bora, İlknur Altuntaş, Oytun Erbaş

DOI: 10.5606/jebms.2023.1044

Issue: 2023, Volume 4 - Issue 1
3114 1194

Exploring Neuroplasticity: The Role of LSD, Methamphetamine, Cannabis, and Ketamine in Psychiatric Disorders

Uğurcan Altıok, Oytun Erbaş

DOI: 10.5606/jebms.2024.1098

Issue: 2024, Volume 5 - Issue 3
6705 1232